Skip to main content

MSF.org

English
العربية
Español
Français

.هذه الصفحة غير متاحة باللغة العربية

Esta página no está disponible en este idioma.

Cette page n’est pas disponible dans cette langue.

This page is not available in this language.

MSF medical guidelines

MSF medical guidelines

Main navigation

Home
Guidelines
Internal guidelines
Updates
Order
About
Favorites
Contact
FAQ

All guidelines

Tuberculosis

Essential drugs

English العربية Spanish French

Clinical guidelines - Diagnosis and treatment manual

English العربية Spanish French

Essential obstetric and newborn care

English العربية French

Management of A CHOLERA EPIDEMIC

English French

Management of A MEASLES EPIDEMIC

English French

Tuberculosis

English French

Public health engineering

English French

Acknowledgements
Foreword
Abbreviations and acronyms
Chapter 1: Introduction and epidemiology
Chapter 2: Clinical presentation
Chapter 3: Diagnosis and follow-up investigations
Chapter 4: Diagnosis of active tuberculosis in children
Chapter 5: Diagnostic algorithm for pulmonary tuberculosis in symptomatic adolescents and adults
Chapter 6: Screening for active tuberculosis
Chapter 7: Case definitions
Chapter 8: Tuberculosis drugs and treatment regimens
Chapter 9: Treatment of drug-susceptible tuberculosis
Chapter 10: Treatment of multidrug-resistant and rifampicin-resistant tuberculosis
Chapter 11: Treatment of rifampicin-susceptible and isoniazid-resistant tuberculosis
Chapter 12: Tuberculosis and HIV co-infection
Chapter 13: Adherence to tuberculosis treatment
Chapter 14: Infection prevention and control
Chapter 15: Follow-up of staff exposed to tuberculosis
Chapter 16: Treatment of latent tuberculosis infection
Chapter 17: Monitoring and evaluation
Appendices

Breadcrumb

Home
Tuberculosis

Chapter 17: Monitoring and evaluation

Select language:

English

(Arabic) العربية

Español (Spanish)

Français (French)

Permalink

On this page

Update: May 2024

17.1 Introduction
17.2 Recording tools
17.3 Case detection and enrolment
17.4 Treatment outcomes
17.5 Organisation assessment

Book traversal links for Chapter 17: Monitoring and evaluation

16.8 Patient monitoring
17.1 Introduction

Send feedback about this page or ask a general question

Name

Email

Your message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MSF medical guidelines

MSF medical guidelines

© Médecins Sans Frontières 2024

Footer

Disclaimer
Cookie Policy
Privacy Notice